November 4, 2011

The Food and Drug Administration has cleared the way for the return to market of a drug for treating immunodeficiency diseases following its recall by the manufacturer in response to patients developing internal blood clots.

May 12, 2010

A drug for treating the bleeding disorder von Willebrand disease has become available, manufacturer Octapharma...